Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus. [electronic resource]
Producer: 20200622Description: 1569-1577 p. digitalISSN:- 1524-4539
- Adamantane -- analogs & derivatives
- Aged
- Benzhydryl Compounds -- adverse effects
- Clinical Decision-Making
- Decision Support Techniques
- Diabetes Mellitus, Type 2 -- complications
- Diabetic Cardiomyopathies -- diagnosis
- Dipeptides -- therapeutic use
- Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
- Female
- Glucosides -- adverse effects
- Health Status
- Heart Failure -- diagnosis
- Humans
- Male
- Middle Aged
- Patient Selection
- Predictive Value of Tests
- Randomized Controlled Trials as Topic
- Reproducibility of Results
- Risk Assessment
- Risk Factors
- Sodium-Glucose Transporter 2 Inhibitors -- adverse effects
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study
There are no comments on this title.
Log in to your account to post a comment.